As of year-end, Cryoport supported a total of 760 global clinical trials, a net increase of 59 clinical trials over FY 2024, with 86 of these clinical trials in Phase 3. The number of trials by phase ...
SCYNEXIS received a one-time non-refundable payment in Q4 2025 totalling $24.8 million from GSK SCYNEXIS announced dosing of the first patient ...
Q4 2025 Earnings Call March 4, 2026 3:00 AM ESTCompany ParticipantsJon Stanton - CEO & DirectorBrian Puffer - CFO ...
Morgan Stanley Technology, Media & Telecom Conference 2026 March 3, 2026 7:05 PM ESTCompany ParticipantsEwout Steenbergen ...
As the AFL premiership gets underway on Thursday, there will be 17 teams furiously trying to stop the Brisbane Lions winning a third straight flag.
Cumberland to highlight 2025 financial, international, portfolio and clinical progressNASHVILLE, Tenn., March 3, 2026 /PRNewswire/ -- Cumberland ...
LAFAYETTE, LA / ACCESS Newswire / March 4, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a ...
Company delivers record fourth quarter and full year net sales of $1.7 billion and $5.3 billion, respectively Fourth quarter net sales grew 5% to ...
Scientists at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) have developed a new way to determine atomic structures from nanocrystals previously considered unusable, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results